Cargando…
Cancer/Testis Antigens: “Smart” Biomarkers for Diagnosis and Prognosis of Prostate and Other Cancers
A clinical dilemma in the management of prostate cancer (PCa) is to distinguish men with aggressive disease who need definitive treatment from men who may not require immediate intervention. Accurate prediction of disease behavior is critical because radical treatment is associated with high morbidi...
Autores principales: | Kulkarni, Prakash, Uversky, Vladimir N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412325/ https://www.ncbi.nlm.nih.gov/pubmed/28362316 http://dx.doi.org/10.3390/ijms18040740 |
Ejemplares similares
-
Cancer/Testis Antigens as Biomarker and Target for the Diagnosis, Prognosis, and Therapy of Lung Cancer
por: Yang, Ping, et al.
Publicado: (2022) -
CETN1 is a cancer testis antigen with expression in prostate and pancreatic cancers
por: Kim, John J, et al.
Publicado: (2013) -
Cancer/Testis antigens as potential predictors of biochemical recurrence of prostate cancer following radical prostatectomy
por: Shiraishi, Takumi, et al.
Publicado: (2011) -
Prostate-associated gene 4 (PAGE4), an intrinsically disordered cancer/testis antigen, is a novel therapeutic target for prostate cancer
por: Kulkarni, Prakash, et al.
Publicado: (2016) -
Derepression of Cancer/Testis Antigens in cancer is associated with distinct patterns of DNA Hypomethylation
por: Kim, Robert, et al.
Publicado: (2013)